Macrogenics, inc. (MGNX)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Operating activities
Cash flows from operating activities
Net loss

-151,518

-151,811

-166,059

-155,457

-166,934

-171,453

-21,082

-34,096

-31,507

-19,626

-160,136

-146,939

-65,820

-58,528

-52,196

-33,792

-95,632

-20,140

-10,707

807

9,924

-38,313

-22,500

-11,968

-3

-261

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense

10,751

10,845

11,130

11,222

9,844

8,279

6,610

5,787

6,588

7,228

7,860

8,032

7,815

7,608

6,826

5,238

4,088

2,863

2,176

2,169

1,970

1,822

1,675

1,510

1,338

1,193

0

0

0

Stock-based compensation

20,263

19,571

18,433

17,608

16,887

16,520

15,848

15,276

14,715

14,744

14,103

13,104

12,625

12,165

11,342

10,438

9,217

7,847

6,626

5,384

4,263

3,244

2,717

1,998

1,329

862

0

0

0

Fair value adjustment of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

626

0

0

0

Changes in operating assets and liabilities:
Accounts receivable

5,691

-16,839

-11,467

-12,224

-1,166

15,941

18,776

15,845

5,188

10,878

-814

-76,384

-418

1,540

264

74,041

792

-1,711

-2,571

1,689

-27

931

3,034

-1,508

-575

-42

0

0

0

Prepaid expenses

4,321

4,878

7,703

6,442

4,980

3,255

1,054

-835

-1,690

-332

1,950

226

3,315

1,677

-673

716

-1,914

-2,405

-469

966

1,680

3,239

1,349

2,029

1,879

834

0

0

0

Other assets

-1,196

1,578

-2,092

20,160

6,699

4,580

9,199

5,314

-383

-262

-1,043

-767

-493

-276

1,184

711

583

285

1,031

950

-215

1,179

0

0

0

-

-

-

0

Accounts payable

1,032

787

2,106

-360

-8,792

1,554

-871

-202

8,494

-1,544

227

561

397

2,232

-1,168

-702

-326

-163

-1,847

-2,124

-3,689

-1,500

2,590

1,858

2,338

-570

0

0

0

Accrued expenses

-3,878

-6,057

-10,632

-7,372

-2,268

3,506

12,791

14,862

12,486

12,832

10,265

9,978

8,270

4,659

6,250

4,036

2,686

3,545

5,089

4,995

4,265

4,346

3,091

2,369

1,474

2,347

0

0

0

Lease liabilities

926

2,881

3,847

231

1,086

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease exit liability

-

-

-

-

-

-

0

0

0

-

0

0

-2,713

-

-2,933

-3,044

-3,385

-3,293

-3,205

-3,119

-1,487

-1,439

-1,230

-1,025

-825

-629

0

0

0

Deferred revenue

-17,687

-20,869

12,098

5,915

9,410

13,405

3,392

5,028

6,163

6,533

-1,937

-2,878

-3,363

-4,191

-5,475

-7,590

-10,167

-12,223

-15,617

-21,688

-10,055

3,317

4,559

7,289

-7,591

-16,676

0

0

0

Deferred rent

-

-

-

-

-

-971

-1,105

6,254

6,129

6,115

6,194

-1,226

-1,180

-1,134

-798

4,537

4,394

4,650

4,564

-533

-152

-234

-180

-101

-21

103

0

0

0

Other liabilities

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-148,412

-134,270

-123,454

-143,046

-151,939

-153,234

-14,161

-8,535

18,441

14,405

-125,769

-44,629

-47,100

-43,679

-39,505

-96,925

-89,164

-13,661

-9,670

-16,367

4,948

-32,759

-13,779

1,359

-4,437

-14,172

0

0

0

Cash flows from investing activities
Cash flows from investing activities
Purchases of marketable securities

243,988

264,399

226,889

188,564

189,895

132,750

166,037

164,676

102,637

135,122

167,189

202,307

321,583

347,762

412,607

345,302

226,026

142,910

0

0

0

-

-

-

-

-

-

-

-

Proceeds from sale and maturities of marketable securities

249,553

189,330

188,736

160,213

168,770

214,348

221,243

229,986

250,687

242,401

258,167

277,788

265,553

288,894

207,733

141,611

73,413

0

0

0

0

-

-

-

-

-

-

-

-

Purchases of property and equipment

3,867

4,289

3,757

7,193

12,110

24,954

34,997

40,631

42,430

29,403

19,707

11,837

10,042

11,381

13,099

13,727

11,031

9,197

8,075

6,139

4,122

3,572

2,838

3,327

2,982

2,961

0

0

0

Net cash provided by (used in) investing activities

1,698

-79,358

-41,910

-35,544

-33,235

56,644

20,209

24,679

105,620

77,876

71,271

63,644

-66,072

-70,249

-217,973

-217,418

-163,644

-152,107

-8,075

-6,139

-4,122

-3,572

-2,838

-3,327

-2,982

-2,961

0

0

0

Cash flows from financing activities
Cash flows from financing activities
Proceeds from issuance of common stock, net of offering costs

0

118,657

118,657

118,657

221,916

103,259

0

0

0

-

-

-

-

-

-

-

-

203,467

203,450

62,675

62,675

76,716

0

0

0

-

-

0

0

Proceeds from stock option exercises and ESPP purchases

1,129

1,315

1,753

1,848

1,711

1,992

1,706

1,602

1,665

1,144

1,226

2,209

1,777

1,893

1,641

837

880

911

890

863

931

744

0

0

0

-

-

-

-

Net cash provided by financing activities

1,129

119,972

120,150

120,245

223,367

104,991

104,875

105,890

35,869

35,348

35,481

35,345

1,738

1,854

1,612

141,583

141,626

204,349

204,321

63,519

63,587

77,441

162,239

162,201

162,615

85,871

0

0

0

Net change in cash and cash equivalents

-145,585

-93,656

-45,214

-58,345

38,193

8,401

110,923

122,034

159,930

127,629

-19,017

54,360

-111,434

-112,074

-255,866

-172,760

-111,182

38,581

186,576

41,013

64,413

41,110

145,622

160,233

155,195

68,738

0

0

0

Supplemental Cash Flow Information [Abstract]
Right-of-use assets modified in exchange for operating lease obligations

4,420

6,408

6,408

1,988

1,988

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-